Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Elevance Health Inc.

    NYSE: ELV · Real-Time Price · USD
    314.00
    2.00 (0.64%)
    At close: Aug 20, 2025, 9:58 AM

    Elevance Health Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 49.78B 48.89B 45.44B 45.15B 43.65B 42.58B 42.65B 42.85B 43.67B 42.17B 39.93B 39.94B 38.63B 38.09B 36.58B 35.82B 33.85B 32.38B
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 49.78B 48.89B 45.44B 45.15B 43.65B 42.58B 42.65B 42.85B 43.67B 42.17B 39.93B 39.94B 38.63B 38.09B 36.58B 35.82B 33.85B 32.38B
    Operating Income
    		 2.29B 2.8B 606M 1.37B 2.99B 2.94B 1B 1.65B 2.44B 2.62B 1.15B 2.13B 2.12B 2.31B 1.4B 2B 2.35B 2.18B
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 2.29B 2.8B 606M 1.37B 2.99B 2.94B 1B 1.65B 2.44B 2.62B 1.15B 2.13B 2.12B 2.31B 1.4B 2B 2.35B 2.18B
    Net Income
    		 1.74B 2.18B 418M 1.02B 2.3B 2.25B 856M 1.29B 1.85B 1.99B 949M 1.6B 1.64B 1.79B 1.14B 1.51B 1.79B 1.67B
    Selling & General & Admin
    		 n/a n/a n/a n/a n/a n/a n/a n/a 4.82B 4.8B 4.56B 4.51B 4.27B 4.34B 4.22B 3.95B 3.82B 3.92B
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 47.48B 46.09B 44.84B 43.77B 40.66B 39.64B 41.65B 41.2B 36.41B 34.75B 34.21B 33.3B 32.24B 31.44B 30.96B 29.88B 27.68B 26.28B
    Operating Expenses
    		 47.48B 46.09B 44.84B 43.77B 40.66B 39.64B 41.65B 41.2B 41.23B 39.55B 38.77B 37.81B 36.51B 35.79B 35.18B 33.83B 31.5B 30.21B
    Interest Expense
    		 341M 344M 340M 300M 280M 265M 259M 259M 261M 251M 229M 213M 208M 201M 200M 201M 205M 192M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 47.48B 46.09B 44.84B 43.77B 40.66B 39.64B 41.65B 41.2B 41.23B 39.55B 38.77B 37.81B 36.51B 35.79B 35.18B 33.83B 31.5B 30.21B
    Income Tax Expense
    		 548M 613M 193M 365M 685M 690M 170M 354M 585M 615M 193M 529M 488M 527M 275M 494M 552M 509M
    Shares Outstanding (Basic)
    		 225.8M 226.4M 227.48M 233.03M 232.2M 232.7M 233.07M 235.3M 236.6M 237.5M 237.96M 239.6M 240.7M 241.4M 241.77M 243.4M 244.5M 245M
    Shares Outstanding (Diluted)
    		 225.8M 227.2M 231.1M 233.1M 233.4M 234.2M 235.8M 236.5M 237.8M 239.7M 241.2M 242.2M 243.4M 244.4M 245.5M 246M 247.4M 248.2M
    EPS (Basic)
    		 7.72 9.64 1.84 4.36 9.91 9.65 3.67 5.48 7.83 8.37 3.64 6.69 6.80 7.41 4.70 6.20 7.33 6.80
    EPS (Diluted)
    		 7.72 9.61 1.81 4.36 9.85 9.59 3.63 5.45 7.79 8.30 3.59 6.62 6.73 7.32 4.63 6.13 7.25 6.71
    EBITDA
    		 3.01B 3.51B 1.34B 2B 3.6B 3.54B 1.68B 2.34B 3.13B 3.33B 1.86B 2.79B 2.72B 2.87B 1.96B 2.55B 2.87B 2.65B
    EBIT
    		 2.63B 3.14B 946M 1.67B 3.27B 3.2B 1.26B 1.91B 2.7B 2.87B 1.38B 2.34B 2.33B 2.51B 1.6B 2.2B 2.56B 2.37B
    Depreciation & Amortization
    		 380M 373M 398M 329M 335M 331M 424M 426M 433M 462M 473M 451M 393M 358M 360M 351M 309M 282M

    Add to Watchlist